These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15288150)

  • 21. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.
    Kanwar M; Hashem M; Rosman H; Kamalakannan D; Cheema A; Ali A; Gardin J; Maciejko JJ
    Am J Cardiol; 2006 Nov; 98(9):1283-7. PubMed ID: 17056347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk acute coronary syndrome patients and cardiac biomarkers in the emergency department: any role for new biomarkers of myocardial ischaemia?
    Roy D; Kaski JC
    Eur Heart J; 2007 Sep; 28(18):2297; author reply 2297-8. PubMed ID: 17673450
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
    May A; Wang TJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk.
    Szeto YT; Kwok TC; Benzie IF
    Nutrition; 2004 Oct; 20(10):863-6. PubMed ID: 15474873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcified coronary artery disease and serum markers].
    Mori K; Jono S
    Clin Calcium; 2007 Mar; 17(3):340-5. PubMed ID: 17339737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):79-84. PubMed ID: 17301631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines and coronary artery disease: the state of the art.
    El-Menyar AA
    Crit Pathw Cardiol; 2008 Jun; 7(2):139-51. PubMed ID: 18520532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin levels and coronary artery disease.
    Chonchol M; Nielson C
    Am Heart J; 2008 Mar; 155(3):494-8. PubMed ID: 18294483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40: a new marker in coronary heart disease.
    Blaton V
    Scand J Clin Lab Invest; 2007; 67(2):113. PubMed ID: 17365990
    [No Abstract]   [Full Text] [Related]  

  • 33. Inflammatory biomarkers in acute coronary syndromes: part III: biomarkers of oxidative stress and angiogenic growth factors.
    Armstrong EJ; Morrow DA; Sabatine MS
    Circulation; 2006 Feb; 113(8):e289-92. PubMed ID: 16505179
    [No Abstract]   [Full Text] [Related]  

  • 34. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting.
    Han JH; Lindsell CJ; Storrow AB; Luber S; Hoekstra JW; Hollander JE; Peacock WF; Pollack CV; Gibler WB;
    Ann Emerg Med; 2007 Feb; 49(2):145-52, 152.e1. PubMed ID: 17145112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of N-terminal pro-BNP-type natriuretic peptide in patients with stable coronary heart disease--secondary publication].
    Kragelund CB; Grønning BA; Køber L; Hildebrandt PR; Steffensen R
    Ugeskr Laeger; 2006 Feb; 168(7):697-700. PubMed ID: 16494811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of educational level with inflammatory markers in the Framingham Offspring Study.
    Loucks EB; Sullivan LM; Hayes LJ; D'Agostino RB; Larson MG; Vasan RS; Benjamin EJ; Berkman LF
    Am J Epidemiol; 2006 Apr; 163(7):622-8. PubMed ID: 16421236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes.
    Miller GE; Freedland KE; Duntley S; Carney RM
    Am J Cardiol; 2005 Feb; 95(3):317-21. PubMed ID: 15670537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.